Skip to main content
. 2026 Aug 7;105(32):e50095. doi: 10.1097/MD.0000000000050095

Table 2.

Visible nail findings.

Visible nail findings PsO without joint involvement PsA AS RA Between PsO and PsA patients Between AS vs RA patients
P value
Between 4 groups
P value P value
Pitting, n (%) 22 (88) 20 (80) 6 (24) 4 (16) .70 .72 < .001
Onycholysis, n (%) 22 (88) 22 (88) 3 (12) 9 (36) 1.0 .09 < .001
Oil drop sign, n (%) 15 (60) 12 (48) 0 0 .39 - < .001
Horizontal ridges, n (%) 6 (24) 9 (36) 3 (12) 2 (8) .35 1.0 .05
Splinter hemorrhage, n (%) 17 (68) 18 (72) 7 (28) 4 (16) .75 .49 < .001
Leukonychia, n (%) 14 (56) 16 (64) 14 (56) 11 (44) .56 .57 .56
Nail plate crumbling, n (%) 4 (16) 3 (12) 0 0 1.0 - .03
Subungual hyperkeratosis, n (%) 10 (40) 17 (68) 4 (16) 3 (12) .04 1.0 < .001
Red lunula, n (%) 8 (32) 8 (32) 1 (4) 2 (8) 1.0 1.0 .01
Vertical ridges-trachyonychia, n (%) 12 (48) 11 (44) 6 (24) 12 (48) .77 .14 .25

Numerical data are expressed as the mean ± SD or median (range). Categorical data are expressed as the frequency (percentage).

AS = ankylosing spondylitis, n = number of patients, PsA = psoriatic arthritis, PsO = psoriasis, RA = rheumatoid arthritis, SD = standard deviation.